AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated March 11, 2024, titled "Intimation about Distribution and Promotion Agreement between AstraZeneca Pharma India Limited ("Company") and Mankind Pharma Limited for innovative budesonide and formoterol fumarate dihydrate (Symbicort)".
Press Release Mar 11 2024
Earlier from Astrazeneca Pharma India
- AstraZeneca Pharma India: Certificate under SEBI (Depositories and Participants) Regulations, 2018
- AstraZeneca Pharma India: Annual General Meeting
- AstraZeneca Pharma India: Schedule of Analysts/Institutional Investor Meet/Con. Call